A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins

被引:24
作者
Lee, Dong-Hwa [1 ]
Ha, Ji-Hyang [1 ]
Kim, Yul [2 ]
Jang, Mi [1 ]
Park, Sung Jean [3 ]
Yoon, Ho Sup [4 ]
Kim, Eun-Hee [5 ]
Bae, Kwang-Hee [6 ]
Park, Byoung Chul [1 ]
Park, Sung Goo [1 ]
Yi, Gwan-Su [2 ]
Chi, Seung-Wook [1 ]
机构
[1] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305806, South Korea
[2] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea
[3] Gachon Univ, Coll Pharm, Inchon 406799, South Korea
[4] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637511, Singapore
[5] Korea Basic Sci Inst, Div Magnet Resonance, Cheongwon 363883, South Korea
[6] Korea Res Inst Biosci & Biotechnol, Res Ctr Integrated Cellul, Taejon 305806, South Korea
基金
新加坡国家研究基金会;
关键词
apoptosis; Bcl-2 family proteins; binding mechanism; DNA-binding domain; p53; STRUCTURAL INSIGHTS; MUTANTS; NUCLEAR; MCL-1; SITE; BAK;
D O I
10.14348/molcells.2014.0001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular interaction between tumor suppressor p53 and the anti-apoptotic Bcl-2 family proteins plays an essential role in the transcription-independent apoptotic pathway of p53. In this study, we investigated the binding of p53 DNA-binding domain (p53DBD) with the anti-apoptotic Bcl-2 family proteins, Bcl-w, Mcl-1, and Bcl-2, using GST pull-down assay and NMR spectroscopy. The GST pull-down assays and NMR experiments demonstrated the direct binding of the p53DBD with Bcl-w, Mcl-1, and Bcl-2. Further, NMR chemical shift perturbation data showed that Bcl-w and Mcl-1 bind to the positively charged DNA-binding surface of p53DBD. Noticeably, the refined structural models of the complexes between p53DBD and Bcl-w, Mcl-1, and Bcl-2 showed that the binding mode of p53DBD is highly conserved among the anti-apoptotic Bcl-2 family proteins. Furthermore, the chemical shift perturbations on Bcl-w, Mcl-1, and Bcl-2 induced by p53DBD binding occurred not only at the p53DBD-binding acidic region but also at the BH3 peptide-binding pocket, which suggests an allosteric conformational change similar to that observed in Bcl-XL. Taken altogether, our results revealed a structural basis for a conserved binding mechanism between p53DBD and the anti-apoptotic Bcl-2 family proteins, which shed light on to the molecular understanding of the transcription-independent apoptosis pathway of p53.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [41] Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
    Bulanova, Daria
    Ianevski, Aleksandr
    Bugai, Andrii
    Akimov, Yevhen
    Kuivanen, Suvi
    Paavilainen, Henrik
    Kakkola, Laura
    Nandania, Jatin
    Turunen, Laura
    Ohman, Tiina
    Ala-Hongisto, Hanna
    Pesonen, Hanna M.
    Kuisma, Marika S.
    Honkimaa, Anni
    Walton, Emma L.
    Oksenych, Valentyn
    Lorey, Martina B.
    Guschin, Dmitry
    Shim, Jungmin
    Kim, Jinhee
    Than, Thoa T.
    Chang, So Young
    Hukkanen, Veijo
    Kulesskiy, Evgeny
    Marjomaki, Varpu S.
    Julkunen, Ilkka
    Nyman, Tuula A.
    Matikainen, Sampsa
    Saarela, Jani S.
    Sane, Famara
    Hober, Didier
    Gabriel, Guelsah
    De Brabander, Jef K.
    Martikainen, Miika
    Windisch, Marc P.
    Min, Ji-Young
    Bruzzone, Roberto
    Aittokallio, Tero
    Vaha-Koskela, Markus
    Vapalahti, Olli
    Pulk, Arto
    Velagapudi, Vidya
    Kainov, Denis E.
    VIRUSES-BASEL, 2017, 9 (10):
  • [42] COOPERATIVE DNA-BINDING OF P53 WITH TFIID (TBP) - A POSSIBLE MECHANISM FOR TRANSCRIPTIONAL ACTIVATION
    CHEN, XB
    FARMER, G
    ZHU, H
    PRYWES, R
    PRIVES, C
    GENES & DEVELOPMENT, 1993, 7 (10) : 1837 - 1849
  • [43] Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy
    O'Neill, J
    Manion, M
    Schwartz, P
    Hockenbery, DM
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2004, 1705 (01): : 43 - 51
  • [44] Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
    Md. Saddam
    Shamrat Kumar Paul
    Mohammad Ahsan Habib
    Md. Abrar Fahim
    Afsana Mimi
    Saiful Islam
    Bristi Paul
    Md Mostofa Uddin Helal
    Egyptian Journal of Medical Human Genetics, 25
  • [45] P53 DOMAINS - IDENTIFICATION AND CHARACTERIZATION OF 2 AUTONOMOUS DNA-BINDING REGIONS
    WANG, Y
    REED, M
    WANG, P
    STENGER, JE
    MAYR, G
    ANDERSON, ME
    SCHWEDES, JF
    TEGTMEYER, P
    GENES & DEVELOPMENT, 1993, 7 (12B) : 2575 - 2586
  • [46] The disordered DNA-binding domain of p53 is indispensable for forming an encounter complex to and jumping along DNA
    Subekti, Dwiky Rendra Graha
    Kamagata, Kiyoto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 534 : 21 - 26
  • [47] Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding
    Wei, Xi
    Wu, Shaofang
    Song, Tanjing
    Chen, Lihong
    Gao, Ming
    Borcherds, Wade
    Daughdrill, Gary W.
    Chen, Jiandong
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (19) : E2558 - E2563
  • [48] The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl
    Xu, HB
    Tai, J
    Ye, H
    Kang, CB
    Yoon, HS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (04) : 938 - 944
  • [49] p53, bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis
    Astudillo, H
    Lopez, T
    Castillo, S
    Gariglio, P
    Benitez, L
    APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 : 771 - 774
  • [50] Structural basis of the p53 DNA binding domain and PUMA complex
    Han, Chang Woo
    Lee, Han Na
    Jeong, Mi Suk
    Park, So Young
    Jang, Se Bok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 548 : 39 - 46